Dear Doctor Letter (Rote-Hand-Brief) on Argatroban solution for infusion 1 mg/ml, ready to use solution for infusion, new formulation: risk of medication error due to possible confusion with Argatroban concentrate solution for infusion which required dilution
2018.08.06
Active substance: argatroban
The marketing authorization holders inform that there is a potential risk of medication errors due to confusion of new ready to use formulations for argatroban with solutions requiring dilution. Confusion of the ready to use formulations with the concentrates can lead to serious under- or overdoses.